期刊文献+

经内镜置支架治疗晚期恶性梗阻性黄疸 被引量:4

Stent placement via endoscopy for advanced malignant obstructive jaundice
下载PDF
导出
摘要 目的探讨应用经内镜置支架治疗晚期恶性梗阻性黄疸的临床疗效及预后。方法回顾分析该科2003年6月~2011年6月292例经内镜置支架治疗晚期恶性梗阻性黄疸患者,对其成功率、并发症发生率、临床疗效和预后等进行分析。结果行经内镜逆行胰胆管造影(ERCP)操作成功率96.23%(281/292),术后1周复查血清生化指标,总胆红素、直接胆红素、谷丙转氨酶与谷草转氨酶均下降明显(P<0.05)。并发症主要是感染、出血、胰腺炎,并发症发生率为7.88%(23/292),经治疗后症状消失,没有操作相关的死亡发生,全组生存期为(7.21±4.68)个月,中位生存时间为7.3个月。结论经内镜置支架治疗晚期恶性梗阻性黄疸操作简单、疗效确切、并发症少,能提高患者的生存质量。 【Objective】To investigate the curative effect and prognosis of advanced malignant obstructive jaun-dice with endoscopic retrograde cholangiopancreatography (ERCP) of metal stent placement.【Methods】Two hun-dreds and ninety-two cases of malignant biliary obstruction whose biliary stent insertions received ERCP from June 2003 to June 2010 in our hospital were reviewed retrospectively. And analysis of the percent of success, incidence of complications, clinic effect and prognosis was made. 【Results】96.23% patients were successfully inserted the bile duct metal stent with ERCP. Compared with the levels of the total bilirubin, direct bilirubin, alkaline phosphatase and alanine aminotransferase before operation ,the indexes decreased one week after the stent insertion (P<0.05). The main complications were infection, hemorrhage and pancreatitis. The incidence rate of complications was about 7.88%.The patients were remission after treatment and there was no operation related dead happened. the survival time was 7.21±4.68 month, the median survival time was 7.3month.【Conclusion】The curative effect in treatment of advanced malignant obstructive jaundice with ERCP of metal stent placement is definite. This method is easily oper-ated and less complications, which improves the patient's quality of life.
出处 《中国内镜杂志》 CSCD 北大核心 2012年第11期1205-1208,共4页 China Journal of Endoscopy
关键词 胆管支架 恶性梗阻性黄疸 经内镜逆行胰胆管造影 biliary stent malignant biliary obstruction endoscopic retrograde cholangiopancreatography (ERCP)
  • 相关文献

参考文献5

二级参考文献29

  • 1何三光.梗阻性黄疸减黄的利弊[J].中国实用外科杂志,1996,16(1):11-13. 被引量:28
  • 2唐采白,胡兵,郭召军.导丝技术在ERCP操作中的应用技巧[J].世界华人消化杂志,2006,14(10):1027-1029. 被引量:15
  • 3[1]Isayama H,Komatsu Y,Tsujino T,Sasahira N,Hirano K,Toda N,Nakai Y,Yamamoto N,Tada M,Yoshida H,Shiratori Y,Kawabe T,Omata M.A prospective randomised study of "covered" versus "uncovered" diamond stents for the man agement of distal malignant biliary obstruction.Gut 2004;53:729-734
  • 4[2]Tsai CC,Mo LR,Lin RC,Kuo JY,Chang KK,Yeh YH,Yang SC,Yueh SK,Tsai HM,Yu CY.Self-expandable metallic stents in the management of malignant biliary obstruction.J Formosa Med Assoc 1996;95:298-302
  • 5[3]Schmassmann A,von Gunten E,Knuchel J,Scheurer U,Fehr HF,Halter F.Wallstents versus plastic stents in malignant biliary obstruction:effects of stent patency of the first and second stent on patient compliance and survival.Am J Gastroenterol 1996;91:654-659
  • 6[4]Thurnher SA,Lammer J,Thurnher MM,Winkelbauer F,Graf O,Wildling R.Covered Self-expanding transhepatic biliary stents:clinical pilot study.Cardiovasc Interv Radiol 1996;19:10-14
  • 7[5]Bezzi M,Zolovkins A,Cantisani V,Salvatori FM,Rossi M,Fanelli F,Rossi P.New ePTFE/FEP-covered stent in the palliative treatment of malignant biliary obstruction.J Vas Interv Radiol2002;13:581-589
  • 8[6]Lee BH,Choe DH,Lee JH,Kim KH,Chin SY.Metallic stents in malignant biliary obstruction:prospective long-term clinical results.A JR 1997;168:741-745
  • 9[7]Rieber A,Brambs HJ.Metallic stents in malignant biliary obstruction.Cardiovasc Interv Radiol 1997;20:43-49
  • 10[8]Arguedas MR,Heudebert GH,Stinnett AA,Wilcox CM.Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma:a cost-effectiveness analysis.Am J Gastroenterol 2002;97:898-904

共引文献39

同被引文献37

引证文献4

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部